INTERRUPTION OF MATERNAL-FETAL TRANSMISSION OF HIV

阻断 HIV 母婴传播

• 批准号: 8357331
• 负责人: JOSEPH M MCCUNE
• 金额: $ 14.36万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-05-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8357331
• 关键词: Address; California; Disease; Funding; Grant; HIV; Immune response; Interruption; Maternal-Fetal Transmission; National Center for Research Resources; Primates; Principal Investigator; Research; Research Infrastructure; Resources; Source; United States National Institutes of Health; Vaccination; Vaccines; Virus; cost; novel strategies; prevent

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. These studies address a novel approach towards vaccination against HIV disease, namely: to create a vaccine that will prevent, rather than to elicit, a robust immune response against the virus.

这个子项目是许多利用资源的研究子项目之一 由NIH/NCRR资助的中心拨款提供。子项目的主要支持 而子项目的主要调查员可能是由其他来源提供的， 包括其它NIH来源。 列出的子项目总成本可能 代表子项目使用的中心基础设施的估计数量， 而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。 这些研究提出了一种针对艾滋病毒疾病的疫苗接种新方法，即：创造一种疫苗，预防而不是引发针对该病毒的强大免疫反应。